Latest news
CEO Johan Wäborg at Redeye Investor Forum
At April 10 Johan Wäborg, CEO at Iconovo presented the company at Redeye Investor Forum in Gothenburg, Sweden.
Iconovo: CEO Johan Wäborg presents…
CEO Johan Wäborg: how do we take GLP-1’s in the future?
Why would you inject yourself… if you could just sniff it? No one likes needles. It becomes a big deal when you’re talking about the world’s most…
Press releases
Jul 12, 2021, 09:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Jul 05, 2021, 14:59
News
IR
Swedish
Corporate Information
Other Corporate Information
Jul 01, 2021, 22:06
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 22:06
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Jul 01, 2021, 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
May 26, 2021, 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 26, 2021, 08:00
News
IR
English
Corporate Information
Other Corporate Information
May 24, 2021, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
May 21, 2021, 08:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
May 20, 2021, 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 20, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
May 19, 2021, 10:07
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 17, 2021, 10:45
News
IR
Swedish
Corporate Information
Other Corporate Information
May 17, 2021, 10:45
News
IR
English
Corporate Information
Other Corporate Information
May 14, 2021, 07:05
News
IR
English
Regulatory
MAR
Corporate Information
Sales
Order
May 14, 2021, 07:05
News
IR
Swedish
Regulatory
MAR
Corporate Information
Sales
Order
Apr 30, 2021, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Apr 29, 2021, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se